Organigram Global Inc.

NASDAQ:OGI

Drug Manufacturers - Specialty & Generic

Healthcare
$0.68 -1.74%

-$0.02 today

Market cap
$95.40M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $0.97High $2.24

Volume 0.62M

Average 0.67M

OGI Account Payables

Amounts the company owes suppliers for goods and services received.

Organigram Global Inc.NASDAQ: OGI

Account Payables · Q2 FY2026 · quarter ended Mar 2026

Account payables rises 16.4% from a year ago

Account payables stood at CA$73.33M at the end of Q2 FY2026, up 16.4% from a year earlier and up 3.2% from the prior quarter.

Context

  • Account payables amounted to 14.0% of total assets at the end of Q2 FY2026, up 2.3 pp from a year earlier.
  • Account payables increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether account payables keeps rising in the next quarterly balance sheet after a +16.4% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$73.33M+3.2% QoQ
Last fiscal yearSep 2025
CA$89.25M+89.5% YoY
Year agoMar 2025
CA$63M+16.4% since
Account Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+16.4%——
1 year+89.5%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Account Payables history

CAD · from the balance sheet

Latest · FY2025
89.25M CAD
Year-over-year change
+89.5%
4-year CAGR
+47.3%

Account Payables vs competitors

How OGI compares with its peers on the latest reported figures

  • Peers report in different currencies, so account payables is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +16.4% is the 4th highest of 9, against a peer median of +14.3%.
  • Account payables amounts to 14.0% of total assets for OGI, versus a peer median of 6.3%.
OGI Competitors
Account Payables for OGI and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
OGIOrganigram Global Inc.Mar 2026CA$73.33M CAD+16.4%—14.0%
ACBAurora Cannabis Inc.Mar 2026CA$50.72M CAD+84.7%-24.8%8.4%
IVAInventiva S.A.Dec 2025€26.01M EUR-20.9%+10.3%10.4%
INFUInfuSystem Holdings, Inc.Mar 2026$9.63M USD+15.1%+9.1%9.8%
DERMJourney Medical CorporationMar 2026$8.67M USD-39.8%-36.9%9.5%
OBIOOrchestra BioMed Holdings, Inc.Mar 2026$6.31M USD+13.5%+15.4%6.3%
LFCRLifecore Biomedical, Inc.Dec 2025$5.84M USD——2.5%
ELMDElectromed, Inc.Mar 2026$2.6M USD+38.1%+28.4%4.4%
HSDTSolana CompanyMar 2026$2M USD+62.7%+44.5%1.0%
RNACCartesian Therapeutics, Inc.Mar 2026$1.6M USD-23.8%+59.7%0.6%
Peer median (excluding OGI) —+14.3%+12.9%6.3%

Competitors are the stored peer set for OGI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Cash & Equivalents55.37M68.52M33.86M106.75M28.2M
Short-term Investments128.48M30.4M0821K826K
Net Receivables21M46.37M27.46M37.15M64.86M
Inventory48.82M68.28M80.95M82.52M123.95M
Other Current Assets5.51M2.21M13.7M25.86M55.39M
Total Current Assets260.62M221.62M155.98M262.22M284.9M
Property, Plant & Equipment (Net)235.94M259.82M99.05M96.23M122.98M
Goodwill14.32M41.98M0052.52M
Intangible Assets2.73M14.26M10.62M8.09M48.51M
Long-term Investments6.11M7.07M13.72M40.73M49.55M
Tax Assets3.2M0000
Other Non-current Assets31.11M32.36M19.09M591K3.75M
Total Non-current Assets293.4M355.48M142.48M145.64M277.31M
Total Assets554.02M577.11M298.46M407.86M562.21M
Account Payables18.95M40.86M14.73M47.1M89.25M
Short-term Debt80K80K76K60K25K
Tax Payables01.42M94K00
Deferred Revenue02.44M000
Other Current Liabilities6.25M12M2.35M5.14M35.91M
Total Current Liabilities26.27M55.29M22.43M53.32M126.16M
Long-term Debt230K155K3.63M25K0
Deferred Tax Liabilities03.62M000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities43.07M7.79M771K45.18M79.17M
Total Non-current Liabilities47.95M13.76M4.4M48.55M86.92M
Total Liabilities74.21M69.05M26.83M101.87M213.08M
Common Stock730.8M769.73M776.91M852.89M919.91M
Retained Earnings(275.64M)(289.93M)(538.53M)(583.97M)(608.73M)
Accumulated OCI24.65M28.26M33.25M37.07M37.95M
Other Stockholders Equity00000
Minority Interest00000
Total Equity479.81M508.06M271.62M305.99M349.13M
Total Debt5.95M3.36M3.71M4.46M8.75M
Net Debt(49.42M)(65.16M)(30.16M)(102.29M)(19.45M)

Organigram Global Inc.

NASDAQ:OGI

Intrinsic Alpha fair value

Locked

Current Price

$0.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.